Search results
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 6 days agoPfizer's Chief Development Officer Roger Dansey said in a statement. CAR-T drugs are developed using...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 1 day agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
'Pandemic proof' vaccine could beat coronaviruses we don't even know about yet
The US Sun· 1 day agoBRITISH scientists reckon they can make a vaccine for coronaviruses we do not even know about yet....
Why Pfizer Stock Blasted More Than 6% Higher Today
Motley Fool via Yahoo Finance· 6 days agoPfizer (NYSE: PFE) stock got a very effective shot in the arm on Wednesday. This was supplied by its latest earnings... Covid effect not as damaging as...
MaineHealth helping test new Lyme vaccine
Portland Press Herald, Maine via Yahoo News· 16 hours agoMay 6—MaineHealth is participating in a research trial that is testing the effectiveness of a potential new Lyme vaccine that could prevent thousands of cases of the disease ...
The true tragedy of the Covid-19 vaccines
The Telegraph via Yahoo News· 6 days agoVaccination is one of mankind’s most miraculous innovations. The eradication of smallpox, and the retreat of measles and other cruel afflictions, mean...
Pfizer Inc (PFE) Q1 2024 Earnings Call Transcript Highlights: Navigating Post-COVID Challenges ...
GuruFocus.com via Yahoo Finance· 6 days agoContinued growth is expected, supported by robust clinical data and effective commercial execution. Q: What is Pfizer's capital allocation strategy, particularly ...
GSK raises forecasts on strong vaccine, HIV drug sales
BioPharma Dive via Yahoo Finance· 6 days agoSales of the shingles vaccine Shingrix and the RSV shot Arexvy helped fuel quarterly revenue totals...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 5 days agovaccine in partnership with Merck. The shot prompts an immune response against a patient's own tumor...
ESCMID 2024: Highlights on prophylaxis and treatment of infectious diseases
Clinical Trials Arena via Yahoo Finance· 6 days agoThe seropositivity rates of individuals at month 126 were 81–95%, depending upon the immunoassay,...
